HCW BIOLOGICS INC's ticker is and the CUSIP is 40423R105. A total of 14 filers reported holding HCW BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,769 | -26.8% | 3,404 | 0.0% | 0.00% | – |
| Q4 2022 | $6,518 | -18.5% | 3,404 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | +700.0% | 3,404 | +580.8% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 72,600 | $160,000 | 0.00% |
| HighTower Advisors, LLC | 225,598 | $495,000 | 0.00% |
| Focused Wealth Management, Inc | 1,000 | $2,000 | 0.00% |
| UBS Group AG | 2,056 | $5,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 39,700 | $87,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 48 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 55,425 | $121,000 | 0.00% |
| STATE STREET CORP | 21,446 | $47,000 | 0.00% |
| MORGAN STANLEY | 500 | $1,000 | 0.00% |